Prediction of the effectiveness and safety of nivolumab for non-small cell lung cancer patients: a retropective cohort study
Phase of Trial: Phase IV
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Mar 2017 Status changed from not yet recruiting to completed, according to results published in the Annals of Oncology.
- 20 Mar 2017 Results published in the Annals of Oncology.
- 13 May 2016 New trial record